Desirudin and Apixaban: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Apixaban
Desirudin
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines are blood thinners. Apixaban (Eliquis) and desirudin (Iprivask) each slow down your body's ability to form clots, just in slightly different ways. When you take them together, their effects add up, so your risk of bleeding goes up too. That bleeding can be serious.
Watch for warning signs like unusual bruising, blood in your urine or stool, black or tarry stools, pink or red urine, nosebleeds that won't stop, or coughing or vomiting blood. If you notice any of these, get help right away or go to the emergency room. The good news is your care team knows about this combination and can watch you closely and manage it safely.
Effect: Additive anticoagulation increasing bleeding risk, potentially fatal. Neither agent is a prodrug; both are active anticoagulants (apixaban is a direct factor Xa inhibitor, desirudin a direct thrombin inhibitor), so the effects are simply additive.
- Magnitude: Apixaban PD studies showed a 50 to 60% rise in anti-Xa activity when combined with enoxaparin; expect comparable additive risk here.
- Evidence/severity: Probable mechanism, major severity.
- Management: Avoid overlap unless clinically necessary. Discontinue apixaban if active pathologic bleeding occurs (PD effect persists >=24 h). Reversal: a specific anti-Xa reversal agent is available; PCC, aPCC, or rFVIIa may be considered. When PCC is used, PT/INR/aPTT or anti-Xa monitoring is not useful. Activated charcoal reduces apixaban absorption.
What happens
An increased risk of bleeding and can cause serious, potentially fatal bleeding
Interaction Deep Dive
When apixaban, a factor Xa inhibitor, is given together with another anticoagulant, the likelihood of bleeding rises. Pharmacodynamic drug interaction studies involving apixaban demonstrated a 50% to 60% rise in anti-factor Xa activity when apixaban and enoxaparin were administered together. If active pathological bleeding develops, apixaban should be stopped. A reversal agent for the anti-factor Xa activity of apixaban is available. Apixaban's pharmacodynamic effect is anticipated to remain for a minimum of 24 hours following the final dose. Patients should be counseled on the signs and symptoms of blood loss and instructed to report them without delay or proceed to an emergency room. Prothrombin complex concentrate (PCC), activated prothrombin complex concentrate, or recombinant factor VIIa may be considered as options. In cases where PCCs are administered, tracking apixaban's anticoagulant effect through a clotting test (PT, INR, or aPTT) or anti-factor Xa (FXa) activity offers no benefit and is not advised. Activated oral charcoal decreases the absorption of apixaban, which in turn reduces apixaban exposure1.
Why it happens (mechanism)
Additive anticoagulation
How to manage this interaction
Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Because two blood thinners together raise bleeding risk, your care team will likely monitor you more closely and may adjust or individualize therapy.
- Learn the signs of bleeding: unusual bruising, red or dark urine, black or bloody stools, nosebleeds that won't stop, coughing or vomiting blood, severe headache, or dizziness.
- Report any of these immediately or go to the emergency room.
- If serious bleeding happens, your medical team can stop apixaban and use reversal options, so this is manageable in a clinical setting.
- Do not start or stop either drug on your own; talk with your pharmacist or doctor with any questions.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In investigations of pharmacodynamic drug interactions involving apixaban, an increase of 50% to 60% in anti-factor Xa activity was noted when apixaban and enoxaparin were given together 1.
Common questions
Can I take Desirudin and Apixaban together?
Taking apixaban and desirudin together adds up two blood thinners and raises your risk of serious bleeding, so your care team should monitor you closely and you should report any signs of bleeding right away. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Desirudin and Apixaban interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Desirudin and Apixaban interaction managed?
Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Because two blood thinners together raise bleeding risk, your care team will likely monitor you more closely and may adjust or individualize therapy. Learn the signs of bleeding: unusual bruising, red or dark urine, black or bloody stools, nosebleeds that won't stop, coughing or vomiting blood, severe headache, or d… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Desirudin or Apixaban need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ELIQUIS(R) oral film coated tablets, apixaban oral film coated tablets. Bristol-Myers Squibb Company (per Dailymed), Princeton, NJ, 2024. DailyMed
Keep reading about Apixaban
Keep reading about Desirudin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist